Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
09/2014
09/10/2014EP2773361A1 Method for improving executive function
09/10/2014EP2773345A1 Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
09/10/2014EP2773341A2 Compositions comprising necrosis inhibitors, such as necrostatins, alone or in combination, for promoting axon regeneration and nerve function, thereby treating cns disorders
09/10/2014EP2773339A1 Composition for improving neuropsychological test battery score
09/10/2014EP2773338A1 Improving recognition
09/09/2014US8829195 Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
09/09/2014US8829194 Crystalline forms of the sodium salt of (4-{4-[5-(6-trifluoromethyl-pyridin-3-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid
09/09/2014US8829158 Peptides, derivatives and analogs thereof, and methods of using same
09/09/2014US8829025 Anti-cancer compounds
09/09/2014US8829024 Combination steroid and glucocorticoid receptor antagonist therapy
09/09/2014US8829020 Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
09/09/2014US8829018 Method of restoring the incretin effect
09/09/2014US8829017 Methods of treating traveler's diarrhea and hepatic encephalopathy
09/09/2014US8828995 Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
09/09/2014US8828994 Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
09/09/2014US8828992 Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating Parkinson's disease using the same
09/09/2014US8828981 Progesterone for the treatment or prevention of spontaneous preterm birth
09/09/2014US8828980 Controlled release corticosteroid compositions and methods for the treatment of otic disorders
09/09/2014US8828978 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
09/09/2014US8828971 Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders
09/09/2014US8828966 Method for treatment of macular degeneration by modulating P2Y12 or P2X7 receptors
09/09/2014US8828960 Amino acid vitamin ester compositions for controlled delivery of pharmaceutically active compounds
09/09/2014US8828959 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells
09/09/2014US8828946 Composition comprising interleukin-1 receptor antagonist and corticosteroid
09/09/2014US8828943 Anticonvulsant combination therapy
09/09/2014US8828927 Elastin digest compositions and methods utilizing same
09/09/2014US8828452 Method for pain control
09/09/2014US8828446 Method for reducing transplant rejection in the eye and intraocular implants for use therefor
09/09/2014US8828438 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors and HMG-CoA reductase
09/09/2014US8828403 Anti-tumor immunotherapy
09/09/2014US8828392 Histone deacetylase (HDAC) inhibitors (PXD101) for the treatment of cancer alone or in combination with chemotherapeutic agent
09/09/2014US8828390 Uses of NOGO-A inhibitors and related methods
09/09/2014US8828358 In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide
09/09/2014US8828232 Citrate-based dialysate chemical formulations
09/09/2014CA2789236C Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use
09/09/2014CA2666582C Acetaminophen / ibuprofen combinations
09/04/2014WO2014134355A1 Drug combinations
09/04/2014WO2014134251A1 Pharmaceutical compositions
09/04/2014WO2014134169A1 Inhibitors of cdk8/19 for use in treating estrogen receptor positive breast cancer
09/04/2014WO2014133729A1 Combined organ and hematopoietic cells for transplantation tolerance of grafts
09/04/2014WO2014131877A1 Protection of the vascular endothelium from immunologically mediated cytotoxic reactions with human cd34-negative progenitor cells
09/04/2014US20140249202 Targeted nanoparticles
09/04/2014US20140249198 Melatonin and its use in preventing postoperative complications
09/04/2014US20140249196 N-benzylbenzimidazole modulators of pparg
09/04/2014US20140249195 7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof
09/04/2014US20140249181 Tropolone compounds for treating or preventing retroviral infection
09/04/2014US20140249168 Trifluoromethyl-substituted fused pyrimidines and their use
09/04/2014US20140249166 Methods of treating patients suffering from movement disorders
09/04/2014US20140249150 Activators of pyruvate kinase m2 and methods of treating disease
09/04/2014US20140249146 4-ALKYL SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS
09/04/2014US20140249138 Azaindoles useful as inhibitors of jak and other protein kinases
09/04/2014US20140249136 Parenteral Formulations of Dopamine Agonists
09/04/2014US20140249133 Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases
09/04/2014US20140249119 Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, processes for their preparation, pharmaceutical preparations comprising them and their use for preparing medicaments
09/04/2014US20140249102 Topical Applicator Composition and Process for Treatment of Radiologically Contaminated Dermal Injuries
09/04/2014US20140249101 Methods for treating hepatitis c virus infection
09/04/2014US20140249100 Compounds, compositions, and methods for preventing metastasis of cancer cells
09/04/2014US20140249099 Cancer therapy
09/04/2014US20140249081 Nanoparticle peptide compositions
09/04/2014US20140249080 Method for the early diagnosis of clinically latent placental insufficiency associated with defective placental maturation
09/04/2014US20140249074 Antiviral compounds
09/04/2014US20140248661 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
09/04/2014US20140248609 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy
09/04/2014US20140248378 Pyrimidinone compounds and their use
09/04/2014US20140248363 Nanoparticulate phosphate adsorbent on the basis of maghemite or maghemite/magnetite, production and uses thereof
09/04/2014US20140248357 Respiratory Disease Treatment
09/04/2014US20140248342 Fe(III) 2,4-Dioxo-1-Carbonyl Complexes For Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anaemias
09/04/2014US20140248335 Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods of use thereof
09/04/2014US20140248313 Combination adjuvant formulation
09/04/2014US20140248289 Methods and Compositions for the Treatment of Respiratory Conditions Via NKG2D Inhibition
09/04/2014US20140248284 Methods for the detection and the treatment of cardiac remodeling
09/04/2014US20140248270 Method for topical treatment of tar-responsive dermatological disorders
09/04/2014US20140248269 Medicinal agent for preventing exacerbation of malignant tumor, comprising combination of natriuretic peptide receptor gc-a and gc-b agonists
09/04/2014US20140248268 Rab7 GTPase Inhibitors and Related Methods of Treatment
09/04/2014US20140248264 Small molecule trail gene induction by normal and tumor cells as an anticancer therapy
09/04/2014US20140248263 Bisphenol compounds and methods for their use
09/04/2014US20140248252 New Salt And Medical Use
09/04/2014US20140248242 Thiophosphate nucleosides for the treatment of hcv
09/04/2014US20140248241 3'-deoxy nucleosides for the treatment of hcv
09/04/2014US20140248240 Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (nampt)
09/04/2014US20140248239 Triazine compounds as pi3 kinase and mtor inhibitors
09/04/2014US20140248237 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
09/04/2014US20140248211 Method of treating cancer
09/04/2014US20140248209 Anti-tumoral compound and relative production process
09/03/2014EP2772260A2 Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
09/03/2014EP2772256A1 Compositions for retarding weight gain associated with use of atypical antipsychotic drugs
09/03/2014EP2772135A2 Medium chain peroxycarboxylic acid compositions
09/03/2014EP2772134A2 Medium chain peroxycarboxylic acid compositions
09/03/2014EP2771241A2 New a-prp medical device&tissue engineering composition, manufacturing machines and process
09/03/2014EP2771034A1 Treatment of patients suffering from cancer
09/03/2014EP2771032A1 Skin lightener in phototherapy
09/03/2014EP2771003A1 Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
09/03/2014EP2770999A1 Method of treating gastrointestinal stromal tumors
09/02/2014US8822685 2,4-pyrimidinediamine compounds and their uses
09/02/2014US8822664 Antibodies
09/02/2014US8822637 Somatostatin analogues
09/02/2014US8822636 Peptides for activation and inhibition of δPKC
09/02/2014US8822526 Synergistic pharmaceutical combination for the treatment of cancer
09/02/2014US8822493 SNS-595 and methods of using the same
09/02/2014US8822488 Compositions of buprenorphine and μ antagonists
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 1151